• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门诊肿瘤诊所中药剂师主导的无缝护理项目的结果评估。

Outcomes assessment of a pharmacist-directed seamless care program in an ambulatory oncology clinic.

作者信息

Edwards Scott J, Abbott Rick, Edwards Jonathan, LeBlanc Michael, Dranitsaris George, Donnan Jennifer, Laing Kara, Whelan Maria A, MacKinnon Neil J

机构信息

Dr H. Bliss Murphy Cancer Center, School of Pharmacy, Memorial University of Newfoundland, St John's, Canada.

出版信息

J Pharm Pract. 2014 Feb;27(1):46-52. doi: 10.1177/0897190013504954. Epub 2013 Sep 24.

DOI:10.1177/0897190013504954
PMID:24065784
Abstract

The primary goal of seamless care is improved patient outcomes and improved standards of care for patients with cancer. The pharmacy service of the Newfoundland Cancer Treatment and Research Foundation conducted a randomized control study that measured clinical and humanistic outcomes of a pharmacist-directed seamless care program in an ambulatory oncology clinic. This article focuses on the intervention group, particularly the identification of drug-related problems (DRPs) and utilization of health care services as well the satisfaction of 3 types of health professionals with the services provided by the pharmacist-directed seamless care program. Overall, the seamless care pharmacist (SCP) identified an average of 3.7 DRPs per intervention patient; the most common DRP reported was a patient not receiving or taking a drug therapy for which there is an indication. The SCP identified more DRPs in patients receiving adjuvant treatment compared to those receiving palliative treatment. On average, family physicians, oncology nurses, and hospital pharmacists were satisfied with the SCP intervention indicating that they agreed the information collected and distributed by the SCP was useful to them. Pharmacist-directed seamless care services in an ambulatory oncology clinic have a significant impact on clinical outcomes and processes of patient care. The presence of a SCP can help identify and resolve DRPs experienced by patients in an outpatient oncology clinic, ensuring that patients are receiving the highest standard of care.

摘要

无缝护理的主要目标是改善癌症患者的治疗效果并提高护理标准。纽芬兰癌症治疗与研究基金会的药学服务部门开展了一项随机对照研究,该研究测量了门诊肿瘤诊所中由药剂师主导的无缝护理项目的临床和人文效果。本文重点关注干预组,特别是药物相关问题(DRP)的识别、医疗服务的利用情况以及三类医疗专业人员对药剂师主导的无缝护理项目所提供服务的满意度。总体而言,无缝护理药剂师(SCP)为每位干预患者平均识别出3.7个DRP;报告的最常见DRP是患者未接受或未服用有适应证的药物治疗。与接受姑息治疗的患者相比,SCP在接受辅助治疗的患者中识别出更多DRP。平均而言,家庭医生、肿瘤护士和医院药剂师对SCP干预感到满意,表明他们认同SCP收集和分发的信息对他们有用。门诊肿瘤诊所中由药剂师主导的无缝护理服务对患者护理的临床结果和过程有重大影响。SCP的存在有助于识别和解决门诊肿瘤诊所患者遇到的DRP,确保患者获得最高标准的护理。

相似文献

1
Outcomes assessment of a pharmacist-directed seamless care program in an ambulatory oncology clinic.门诊肿瘤诊所中药剂师主导的无缝护理项目的结果评估。
J Pharm Pract. 2014 Feb;27(1):46-52. doi: 10.1177/0897190013504954. Epub 2013 Sep 24.
2
Implementing a standardized pharmacist assessment and evaluating the role of a pharmacist in a multidisciplinary supportive oncology clinic.实施标准化的药剂师评估,并评估药剂师在多学科支持性肿瘤诊所中的作用。
J Support Oncol. 2012 May-Jun;10(3):99-106. doi: 10.1016/j.suponc.2011.09.005. Epub 2012 Jan 23.
3
Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study.接受药物治疗管理的血液透析患者的药物使用量和住院率降低:一项为期 2 年的随机对照研究。
Pharmacotherapy. 2009 Dec;29(12):1433-40. doi: 10.1592/phco.29.12.1433.
4
The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.药剂师管理的门诊诊所及用于监测口服化疗的化疗指导电子医嘱集的影响
J Oncol Pharm Pract. 2017 Dec;23(8):582-590. doi: 10.1177/1078155216672314. Epub 2016 Oct 12.
5
Clinical outcomes of a home-based medication reconciliation program after discharge from a skilled nursing facility.熟练护理机构出院后居家用药核对计划的临床结局
Pharmacotherapy. 2008 Apr;28(4):444-52. doi: 10.1592/phco.28.4.444.
6
Impacts of Pharmacists-Managed Oncology Outpatient Clinic on Resolving Drug-Related Problems in Ambulatory Neoplasm Patients: A Prospective Study in China.药剂师管理的肿瘤门诊对解决门诊肿瘤患者药物相关问题的影响:中国的一项前瞻性研究。
Inquiry. 2021 Jan-Dec;58:469580211009662. doi: 10.1177/00469580211009662.
7
Characterization of drug-related problems and associated factors in ambulatory patients in China.中国门诊患者药物相关问题及相关因素的特征分析
J Clin Pharm Ther. 2020 Oct;45(5):1058-1065. doi: 10.1111/jcpt.13161. Epub 2020 Jun 9.
8
Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial.药剂师主导的基层医疗结构化药物审查对药物相关问题和住院率的影响:一项随机对照试验
Scand J Prim Health Care. 2014 Dec;32(4):180-6. doi: 10.3109/02813432.2014.972062. Epub 2014 Oct 27.
9
Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic.在一个门诊药物治疗临床药师干预下,对药物相关问题进行识别。
J Clin Pharm Ther. 2022 Jul;47(7):964-972. doi: 10.1111/jcpt.13628. Epub 2022 Feb 26.
10
Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.临床药师在门诊环境中进行抗心律失常药物监测的初步经验:一项回顾性研究。
Clin Ther. 2009 Jun;31(6):1209-18. doi: 10.1016/j.clinthera.2009.06.014.

引用本文的文献

1
Optimizing Adjuvant Care in Early Breast Cancer: Multidisciplinary Strategies and Innovative Models from Canadian Centers.优化早期乳腺癌的辅助治疗:来自加拿大各中心的多学科策略与创新模式
Curr Oncol. 2025 Jul 14;32(7):402. doi: 10.3390/curroncol32070402.
2
Medication Risks and Their Association with Patient-Reported Outcomes in Inpatients with Cancer.癌症住院患者的用药风险及其与患者报告结局的关联
Cancers (Basel). 2024 May 31;16(11):2110. doi: 10.3390/cancers16112110.
3
Clinical and economic impact of clinical oncology pharmacy in cancer patients receiving injectable anticancer treatments: a systematic review.
癌症患者接受注射用抗肿瘤药物治疗时临床肿瘤药学的临床和经济影响:系统评价。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7905-7924. doi: 10.1007/s00432-023-04630-4. Epub 2023 Feb 28.
4
The oncology pharmacist as part of the palliative treatment team.肿瘤药师作为姑息治疗团队的一员。
Int J Pharm Pract. 2020 Feb;28(1):92-96. doi: 10.1111/ijpp.12583. Epub 2019 Oct 1.
5
Impact of informational and relational continuity for people with palliative care needs: a mixed methods rapid review.有姑息治疗需求人群的信息和关系连续性的影响:混合方法快速综述。
BMJ Open. 2019 May 29;9(5):e027323. doi: 10.1136/bmjopen-2018-027323.
6
2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard.2018 年血液病/肿瘤药师协会口腔肿瘤治疗管理最佳实践:药学实践标准。
J Oncol Pract. 2019 Apr;15(4):e346-e355. doi: 10.1200/JOP.18.00581. Epub 2019 Mar 12.
7
Pharmacist services for non-hospitalised patients.针对非住院患者的药剂师服务。
Cochrane Database Syst Rev. 2018 Sep 4;9(9):CD013102. doi: 10.1002/14651858.CD013102.
8
Network analysis of drug-related problems in hospitalized patients with hematologic malignancies.对血液恶性肿瘤住院患者药物相关问题的网络分析。
Support Care Cancer. 2018 Aug;26(8):2737-2742. doi: 10.1007/s00520-018-4106-4. Epub 2018 Feb 27.
9
The need for community pharmacists in oncology outpatient care: a systematic review.肿瘤门诊护理中社区药剂师的需求:一项系统综述
Int J Clin Pharm. 2016 Aug;38(4):855-62. doi: 10.1007/s11096-016-0297-2. Epub 2016 Apr 7.
10
Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor pathway for the treatment of breast cancer.用于治疗乳腺癌的 PI3K/Akt/mTOR 通路抑制剂的新型药物及相关毒性。
Curr Oncol. 2015 Feb;22(1):33-48. doi: 10.3747/co.22.2393.